| Dabigatran versus warfarin in patients with atrial fibrillation SJ Connolly, RBPMD Ezekowitz, S Yusuf, J Eikelboom, J Oldgren, ... New England journal of medicine 361 (12), 1139-1151, 2009 | 14346 | 2009 |
| Rivaroxaban versus warfarin in nonvalvular atrial fibrillation MR Patel, KW Mahaffey, J Garg, G Pan, DE Singer, W Hacke, G Breithardt, ... New England Journal of Medicine 365 (10), 883-891, 2011 | 11605 | 2011 |
| Apixaban in patients with atrial fibrillation SJ Connolly, J Eikelboom, C Joyner, HC Diener, R Hart, S Golitsyn, ... New England Journal of Medicine 364 (9), 806-817, 2011 | 3328 | 2011 |
| Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial PS group, RBP group( The Lancet 371 (9627), 1839-1847, 2008 | 2587 | 2008 |
| Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries CK Chow, KK Teo, S Rangarajan, S Islam, R Gupta, A Avezum, ... Jama 310 (9), 959-968, 2013 | 2208 | 2013 |
| Prognostic value of grip strength: findings from the Prospective Urban Rural Epidemiology (PURE) study DP Leong, KK Teo, S Rangarajan, P Lopez-Jaramillo, A Avezum Jr, ... The Lancet 386 (9990), 266-273, 2015 | 1808 | 2015 |
| Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort … S Yusuf, P Joseph, S Rangarajan, S Islam, A Mente, P Hystad, M Brauer, ... The Lancet 395 (10226), 795-808, 2020 | 1413 | 2020 |
| The effect of physical activity on mortality and cardiovascular disease in 130 000 people from 17 high-income, middle-income, and low-income countries: the PURE study SA Lear, W Hu, S Rangarajan, D Gasevic, D Leong, R Iqbal, A Casanova, ... The Lancet 390 (10113), 2643-2654, 2017 | 1334 | 2017 |
| Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis … L Wallentin, S Yusuf, MD Ezekowitz, M Alings, M Flather, MG Franzosi, ... The Lancet 376 (9745), 975-983, 2010 | 1298 | 2010 |
| Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke RL Sacco, HC Diener, S Yusuf, D Cotton, S Ôunpuu, WA Lawton, ... New England Journal of Medicine 359 (12), 1238-1251, 2008 | 1270 | 2008 |
| Associations of fats and carbohydrate intake with cardiovascular disease and mortality in 18 countries from five continents (PURE): a prospective cohort study M Dehghan, A Mente, X Zhang, S Swaminathan, W Li, V Mohan, R Iqbal, ... The Lancet 390 (10107), 2050-2062, 2017 | 1197 | 2017 |
| Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: the OASIS-6 randomized trial. S Yusuf, SR Mehta, S Chrolavicius, J Pogue, CB Granger, A Budaj, ... JAMA: Journal of the American Medical Association 295 (13), 2006 | 1182 | 2006 |
| Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective … S Yusuf, S Islam, CK Chow, S Rangarajan, G Dagenais, R Diaz, R Gupta, ... The Lancet 378 (9798), 1231-1243, 2011 | 1083 | 2011 |
| Telmisartan to prevent recurrent stroke and cardiovascular events S Yusuf, HC Diener, RL Sacco, D Cotton, S Ôunpuu, WA Lawton, ... New England Journal of Medicine 359 (12), 1225-1237, 2008 | 1046 | 2008 |
| Urinary sodium and potassium excretion, mortality, and cardiovascular events M O'Donnell, A Mente, S Rangarajan, MJ McQueen, X Wang, L Liu, H Yan, ... New England Journal of Medicine 371 (7), 612-623, 2014 | 1041 | 2014 |
| Association of urinary sodium and potassium excretion with blood pressure A Mente, MJ O'Donnell, S Rangarajan, MJ McQueen, P Poirier, ... New england journal of medicine 371 (7), 601-611, 2014 | 978 | 2014 |
| The effect of dabigatran plasma concentrations and patient characteristics on the frequency of ischemic stroke and major bleeding in atrial fibrillation patients: the RE-LY … PA Reilly, T Lehr, S Haertter, SJ Connolly, S Yusuf, JW Eikelboom, ... Journal of the American College of Cardiology 63 (4), 321-328, 2014 | 978 | 2014 |
| Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial. SR Mehta, S Yusuf, R Díaz, J Zhu, P Pais, D Xavier, E Paolasso, R Ahmed, ... Jama 293 (4), 437-446, 2005 | 887 | 2005 |
| Treatment and outcomes of acute coronary syndromes in India (CREATE): a prospective analysis of registry data D Xavier, P Pais, PJ Devereaux, C Xie, D Prabhakaran, KS Reddy, ... The Lancet 371 (9622), 1435-1442, 2008 | 838 | 2008 |
| Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY … JS Healey, J Eikelboom, J Douketis, L Wallentin, J Oldgren, S Yang, ... Circulation 126 (3), 343-348, 2012 | 700 | 2012 |
Salim YusufPopulation Health Research Institute, McMaster University and Hamilton Health Sciences在 mcmaster.ca 的电子邮件经过验证
